Biopharmaceutical Research Company (BRC), a Monterey, California-based organization which holds a valid Drug Enforcement Administration (DEA) pharmaceutical cannabis license, in Series A funding raised a total of $20 million. Achari Ventures, Argonautic Ventures, AFI Capital Partners, Self Health America, Delta Emerald Ventures, and several distinguished private equities participated in the round, which Intrinsic Capital Partners spearheaded.
However, a glimmer of hope has emerged from an unlikely source: cannabis. Some individuals with…
Nevertheless, this thought experiment raises a crucial issue that we, as a society, must grapple…
Find the best delta-9 THC gummies of 2024. Leafly reviewed popular delta-9 THC gummies &…
We shall look at the top 10 Twitter (X) handles that offer exclusive information to…
Understanding how long marijuana stays in saliva i s crucial for various reasons, including legal…
Alright, let's dive into this groundbreaking study with all the seriousness it deserves - which…